Post

Cellf Bio’s first-in-human implantation of BioSphincter

Cellf Bio has reported the first human implantation of its autologous bioengineered sphincter BioSphincter in a Phase I clinical trial …

Cue Health gets FDA approval for Covid-19 at-home test

Cue Health has obtained de novo authorisation from the US Food and Drug Administration (FDA) for its Covid-19 at-home test, …

Increasing cataract surgical rates to drive growth of global artificial lens market

June is Cataract Awareness Month, a time aimed at raising awareness for the world’s leading cause of blindness. According to …

Olympus introduces new ESG-410 electrosurgical generator

Medical technology company Olympus has introduced its new ESG-410 electrosurgical generator to treat enlarged prostate and bladder cancer. The electrosurgical generator …

Digital nutrition platform secures $15m cash injection

New York-based life science company Mend has received a $15 million series A investment from a consortium of venture firms …